Today: 9 June 2026
UOB share price slips as MAS turns slightly hawkish — what investors watch next
30 January 2026
2 mins read

UOB share price slips as MAS turns slightly hawkish — what investors watch next

Singapore, Jan 30, 2026, 14:51 SGT — Regular session

  • UOB shares dropped 0.6% on Friday, while Singapore bank stocks showed a mixed performance.
  • MAS left policy unchanged but lifted its inflation forecast for 2026, rattling some risk bets.
  • Attention shifts to UOB’s Feb. 24 earnings for clues on margins and credit costs.

United Overseas Bank Ltd (UOB) shares dipped 0.6% to S$38.41 on Friday, slipping 24 Singapore cents from Thursday’s finish. Trading remained uneven following a solid rally in local banks. The stock fluctuated between S$38.40 and S$38.65. Meanwhile, DBS dropped 0.8% and OCBC inched up 0.2%.

The pullback is significant since Singapore’s banks have been carrying much of the weight for local equities. Investors are now wrestling with how “higher for longer” inflation could impact earnings, trying not to get ahead of themselves on valuations.

This comes as the earnings season is about to heat up. UOB won’t report for several weeks yet, but investors are already focusing intently on guidance—particularly around loan quality and the direction of margins.

On Thursday, the Monetary Authority of Singapore held its exchange-rate policy steady but raised its 2026 core and headline inflation forecasts to 1.0%–2.0%, up from 0.5%–1.5%, citing upside risks to growth and inflation. OCBC economist Selena Ling described the central bank’s tone as “a tad more hawkish and less dovish,” while Maybank’s Chua Hak Bin noted “simmering inflation pressures emerging.” Reuters

Brokers pushed prices higher, only to pull them back again. According to The Business Times, UOB’s consensus target price climbed to S$37.26, even as the stock lingered above that mark after hitting a record S$39.50 last week. Macquarie’s Jayden Vantarakis labeled UOB a “catch-up play,” while JPMorgan downgraded its rating to “underweight.”

Traders see it plainly: the rally already baked in plenty of good news, so minor changes in the macro outlook can spark profit-taking. UOB’s Friday move felt more like repositioning than a reaction to new company developments.

Feb. 24 is the next key date. UOB announced in an exchange filing that it will publish its full-year 2025 financial results ahead of the market open that day.

Investors are keenly eyeing any shift in the bank’s forecast for net interest margin — the difference between earnings on loans and expenses on deposits — along with updates on credit costs and fee income. Signals about dividends will also draw attention, especially following the stock’s strong rally this month.

UOB has flagged a potential dip in margins as the rate cycle shifts. Back in November, the bank forecast its full-year 2026 net interest margin to land between 1.75% and 1.80%, which is lower than its 2025 estimate. It also projected total credit costs to range from 25 to 30 basis points.

There is a downside risk. Should inflation remain stubborn and policy tighten further later this year, funding costs might outpace asset yields. A shaky global economy could also trigger a swift rise in credit provisions, particularly for a regionally-focused lender like UOB.

Investors are now eyeing UOB’s report due Feb. 24, with keen interest in what management reveals about margins and loan stress as 2026 approaches.

Stock Market Today

  • Aker BP Share Price Surges Amid Valuation Debate
    June 9, 2026, 11:54 AM EDT. Aker BP (OB:AKRBP) shares climbed to NOK347.7, marking a 55.05% total shareholder return over one year, outperforming peers in Norway's energy sector. Despite this momentum, the stock trades at an 8.6% premium over a fair value of NOK320.11, raising questions about valuation. The company aims to sustain production above 500,000 barrels per day past 2030, backed by projects like Yggdrasil and Johan Sverdrup, supporting revenue growth. Yet, potential risks include higher emissions costs and delays in key developments. Analysts offer cautious pricing, but a discounted cash flow (DCF) model from Simply Wall St suggests a much higher intrinsic value of NOK1,769.75, indicating significant undervaluation. Investors face a valuation divide between conservative targets and optimistic cash flow projections.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Accenture stock slides 3% as new share award pool wins approval — what investors watch next
Previous Story

Accenture stock slides 3% as new share award pool wins approval — what investors watch next

GSK share price dips in London as Exdensur rollout and Feb 4 results loom
Next Story

GSK share price dips in London as Exdensur rollout and Feb 4 results loom

Go toTop